10 December 2024: Clinical Research
Evaluating Lipiodol Efficacy in Proximal Tubal Occlusion Treatment: Single-Center Experience and Literature Review
Maciej Szmygin 1ABCDEF*, Bartosz Kłobuszewski1ABCDEF, Karolina Nieoczym 2ABCDEF, Ireneusz Zych3ABCDEF, Magdalena Wierzchowska-Opoka 3ABCD, Hanna Szmygin 4ABCDEF, Sławimir Woźniak 5ABC, Bożena Leszczyńska-Gorzelak 3ABD, Krzysztof Pyra 1ABCDEFDOI: 10.12659/MSM.946266
Med Sci Monit 2024; 30:e946266
Abstract
BACKGROUND: Tubal infertility caused by proximal occlusion of fallopian tubes is a common cause of female infertility. Lipiodol (ethiodized oil) is an oil-based iodinated contrast medium, previously used in hysterosalpingography, and is now used as a therapeutic agent. This single-center study aimed to evaluate the experience of outcomes from the use of Lipiodol in 96 women with infertility due to fallopian tube occlusion.
MATERIAL AND METHODS: In total, 96 women with infertility caused by tubal obstruction, confirmed in hysterosalpingography and/or laparoscopy, who underwent tubal recanalization followed by Lipiodol injection were enrolled. Information regarding the reproductive outcome at a minimum of 6 months following the treatment was collected by a telephone survey or direct contact. Pregnancy rate was calculated.
RESULTS: Average age on admission was 33±4.1 years. In most cases (79%, 76/96), infertility was primary. Average duration of infertility was 2.8 years. Comorbidities included endocrinopathies and endometriosis. Complete patency was achieved in 96% of cases (92/96 patients). In 4 cases (4%), distal occlusion of 1 ovary was observed, resulting in partial procedural success. Tubal catheterization was needed in 29 patients (30%). No procedural complications were noted. Thirty-four patients conceived, resulting in a 35.8% pregnancy rate. Miscarriage was noted in 5 patients, and tubal ectopic pregnancy in 1 patient. No long-term complications were reported.
CONCLUSIONS: Our results show that use of oil-based contrast for tubal recanalization is safe and effective treatment for proximal tubal occlusion, with a relatively high pregnancy rate (36%). Further studies are required to fully discover its potential benefits.
Keywords: Fallopian Tube Diseases, Hysterosalpingography, Reproductive Medicine
Introduction
Infertility is described as a medical condition referring to the inability to become clinically pregnant after 1 year of consistent unprotected sexual intercourse in women under the age of 35 years, or after 6 months in women aged 35 years and older [1]. Infertility is a widespread problem affecting around 186 million people worldwide and 8% to 12% of couples of reproductive age [2,3]. Although in 30% of infertile couples it is impossible to determine the exact cause of infertility, most cases are successfully diagnosed, and appropriate treatment can be initiated. Among the causes of female infertility, the most common are ovarian dysfunction and tubal disease [1].
Tubal infertility accounts for up to 67% of infertility diagnoses, of which proximal tubal occlusion is estimated to range from 10% to 25% [4]. The blockage of the fallopian tubes impairs the processes of oocyte retrieval, fertilization, and transport of the fertilized egg, ultimately leading to infertility [5]. This condition can result from various factors, including infection and subsequent inflammation, endometriosis, polyps, or salpingitis isthmica [1]. Laparoscopy with chromopertubation is routinely performed in the diagnosis of fallopian tube obstruction. Despite the significant advantages of this type of diagnosis and the possibility of an accurate assessment of the pelvic anatomy, the use of minimally invasive methods, such as hysterosalpingography and contrast-enhanced hysterosalpingo-sonography, are considered the preferred methods, as they allow simultaneous selective salpingography and recanalization if a proximal fallopian tube obstruction is identified [6]. The treatment of fallopian tube obstruction is also achieved through methods such as microsurgical procedures, radiological treatments, hormonal therapies, and in vitro fertilization (IVF) techniques. Recanalization is an effective and minimally invasive treatment for proximal obstructions and is considered an excellent alternative to extensive surgery [4]. A large, multicenter, and randomized study by van Rijswijk et al showed a significant advantage of using oil-soluble contrast over water-soluble contrast when performing hysterosalpingography, as it was associated with higher pregnancy rates and was a cost-effective strategy, compared with hysterosalpingography with water-based contrast for infertile, ovulating women, with a low risk of fallopian tube pathology [7]. Lipiodol is the most commonly used oil-soluble contrast under fluoroscopy and ultrasonographic guidance, with a relatively high clinical success rate and low complication rate [8].
Therefore, this single-center study aimed to evaluate the experience of outcomes from the use of Lipiodol (ethiodized oil) in 96 women with infertility caused by fallopian tube occlusion.
Material and Methods
ETHICAL STATEMENT:
All individuals gave their informed consent for the study. All procedures were conducted in accordance with the Declaration of Helsinki. The local ethics committee approved this study.
STUDY DESIGN:
This was a retrospective and single-center study that included 96 consecutively enrolled female patients with infertility caused by tubal obstruction who underwent selective salpingography and tubal catheterization followed by Lipiodol injection from January to December 2023. Prior to the treatment, medical history of the patient and her male partner was collected.
INCLUSION AND EXCLUSION CRITERIA:
Inclusion criteria included (1) primary or secondary female infertility of at least 12 months, and (2) tubal occlusion confirmed prior to the treatment, either with hysterosalpingography, hysterosalpingo-sonography, or laparoscopy. The following exclusion criteria were applied: (1) history of tubal ectopic pregnancy, (2) known iodine and/or Lipiodol allergy, and (3) lack of informed consent for participation in the study.
FALLOPIAN TUBE RECANALIZATION PROCEDURE:
All patients received a course of antibiotics with doxycicline 100 mg orally 2 times a day for a period of 5 days starting 2 days before the procedure. Additionally, treatment with ketoprofen and/or paracetamol was routinely administered intravenously during the procedure.
All procedures were performed in the follicular phase of the menstrual cycle by an experienced gynecologist and radiologist. In a sterile condition, a balloon catheter ranging from 5 to 12 Fr was inserted into the uterine cavity and inflated to block internal os. Afterward, the contrast media (iodixanol, Visipaque 320, Amersham Health, UK) was injected into the inner fallopian tube ostia via a catheter (5 Fr Kumpe catheter, Cook, Bloomington, IN, USA). In case of proximal visible tubal occlusion, catheterization with 0.035″ guidewire (Terumo, Tokyo, Japan) was performed. Once the tubal patency was obtained (defined as bilateral spill into the peritoneal cavity), repeated contrast injection was performed. Finally, 10 mL of Lipiodol (Guerbet Pharmaceuticals, Paris, France) was instilled as a therapeutic agent. In our institution, all measures are taken to reduce the radiation dose in case of interventions involving female patients in childbearing age, according to the “as low as reasonably achievable principle”. Therefore, all procedures were performed with short fluoroscopy pulses and tight collimation. After the procedure, all patients remained at the Gynecological Department and were discharged in the afternoon if no complaints were reported. A typical procedure of selective salpingography followed by tubal catheterization is presented in Figure 1.
FOLLOW-UP PROTOCOL:
Information regarding the reproductive outcome at a minimum of 6 months following the treatment was collected either by a telephone survey or direct contact with the patient.
STATISTICAL ANALYSIS:
The measurement data are expressed as mean±standard deviation, and ranges are provided.
Results
DEMOGRAPHIC FINDINGS:
The final study cohort included 96 women diagnosed with tubal infertility. Average age on admission was 33±4.1 years (range 26–45 years). In most cases (79%, 76/96) infertility was primary, and the most common diagnostic tool used prior to the procedure was hysterosalpingography and/or hysterosalpingo-sonography (66%), laparoscopy and hysterosalpingography (19%), and laparoscopy (15%).
INFERTILITY DETAILS:
As far as the pre-procedural treatments for infertility were concerned, 35 couples (36%) tried ovulation induction, 6 (6%) tried IVF, 5 (5%) tried intrauterine insemination, and 23 (24%) tried other methods. The average duration of infertility was 2.8 years (range 1–11 years).
COMORBIDITIES:
The most common comorbidities were endocrinopathies (21%, 20/96) and endometriosis (8%, 8/96). Six patients (6%) had a history of gynecological operation that resulted in unilateral oophorectomy. Additionally, in 2 patients, bicornuate uterus was diagnosed.
PARTNER’S FERTILITY STATUS:
In terms of male partner fertility status, 26% (25/96) reported oligospermia, and 5% (5/96) had a diagnosis of varicoceles.
PROCEDURAL OUTCOME:
As for procedural results, complete patency was achieved in 96% of patients (92/96 patients). In 4 patients (4%), distal occlusion of one of the ovaries was observed, resulting in partial procedural success. In most cases (67/96, 70%), selective salpingography was sufficient to restore tubal patency. Tubal catheterization was needed in 29 patients (30%). Once the tubal patency was obtained, Lipiodol was injected until spill into the peritoneal cavity was observed. No procedural complications were noted. The average radiation dose was 37.5±40.8 mGy (range 4–229 mGy).
POST-PROCEDURAL DETAILS:
After the procedure, minor vaginal bleeding, uterine cramping, and pain were frequent symptoms. Nonetheless, no serious adverse events were noted. All patients were discharged in good clinical condition a few hours after the procedure.
REPRODUCTIVE OUTCOMES:
Reproductive outcomes at a minimum of 6 months (follow-up ranging from 6 to 18 months) after the treatment were collected by a telephone survey. One patient was lost to follow-up and therefore excluded from further analysis. From the remaining 95 women who answered the survey, 34 conceived, resulting in a 35.8% overall pregnancy rate. From this group, in 74% (24/34) of patients, selective salpingography was performed, and 26% (10/34) required tubal catheterization. Miscarriage was noted in 5 patients, and tubal ectopic pregnancy in 1 patient. No long-term complications were reported. Demographic data, clinical data, procedural details, and outcomes are presented in Table 1.
Discussion
STUDY LIMITATIONS:
Our study had several limitations. First, our sample size was relatively small, and subgroup analysis was not possible. That is why the significance of our results and of the conclusions requires further validation in future studies. We are planning to continue to investigate the outcomes of tubal recanalization with oil-based contrast in our institution and will provide more date in the future. Second, our study lacked a control arm including patients treated with other methods, especially laparoscopic methods. Nonetheless, despite potentially wide opportunities for surgical methods in the treatment of proximal tubal occlusion, less invasive radiological methods are preferred in many centers, including ours. Finally, we did not provide a very long-term follow-up, which might increase the overall pregnancy rate, hence the potential bias of the study. However, it has been reported by several authors mentioned in our paper that most pregnancies occur within the first 6 months after the procedure.
Conclusions
In summary, the results of our center’s 1-year experience with oil-based contrast medium for selective salpingography and tubal catheterization show that it is a safe and effective treatment with a relatively high pregnancy rate and acceptably low complication rate. Further studies with subgroup analysis, including comorbidities, primary vs secondary infertility, and partner’s fertility status, are required to fully discover the potential benefits of this method.
References
1. Roberts A, Fallopian tube recanalization for the management of infertility: CVIR Endovasc, 2023; 6(1); 13
2. El-Kharoubi AF, Tubal pathologies and fertility outcomes: A review: Cureus, 2023; 15(5); e38881
3. Carson SA, Kallen AN, Diagnosis and management of infertility: A review: JAMA, 2021; 326(1); 65-76
4. Serafini P, Batzofin J, Diagnosis of female infertility. A comprehensive approach: J Reprod Med, 1989; 34(1); 29-40
5. Han J, Sadiq NM, Anatomy, abdomen and pelvis: fallopian tube: StatPearls July 24, 2023, Treasure Island (FL), StatPearls Publishing
6. Mody P, Salazar G, Kohi MP, Recanalization of Proximal Fallopian Tube Obstruction in the Treatment of Infertility: Semin Intervent Radiol, 2023; 40(4); 379-83
7. van Rijswijk J, Pham CT, Dreyer K, Oil-based or water-based contrast for hysterosalpingography in infertile women: A cost-effectiveness analysis of a randomized controlled trial: Fertil Steril, 2018; 110(4); 754-60
8. Peart J, Sim R, Safety of Lipiodol use for assessment of tubal patency and therapeutic tubal flushing – fluoroscopy versus ultrasound?: J Med Imaging Radiat Oncol, 2020; 64(4); 522-24
9. Ambildhuke K, Pajai S, Chimegave A, A review of tubal factors affecting fertility and its management: Cureus, 2022; 14(11); e30990
10. Vitale SG, Carugno J, Riemma G, Hysteroscopy for assessing fallopian tubal obstruction: A systematic review and diagnostic test accuracy meta-analysis: J Minim Invasive Gynecol, 2021; 28(4); 769-78
11. Panchal S, Nagori C, Imaging techniques for assessment of tubal status: J Hum Reprod Sci, 2014; 7(1); 2-12
12. Matsumoto H, Fukuda A, Mizuno S, Effect of X-ray exposure during hysterosalpingography on capabilities of female germ cells: J Assist Reprod Genet, 2021; 38(12); 3233-42
13. Maheux-Lacroix S, Bergeron C, Moore L, Hysterosalpingosonography is not as effective as hysterosalpingography to increase chances of pregnancy: J Obstet Gynaecol Can, 2019; 41(5); 593-98
14. Ott J, Hager M, Nouri K, Assessment of tubal patency: A prospective comparison of diagnostic hysteroscopy and laparoscopic chromopertubation: J Minim Invasive Gynecol, 2020; 27(1); 135-40
15. Tanaka Y, Tajima H, Sakuraba S, Renaissance of surgical recanalization for proximal fallopian tubal occlusion: falloposcopic tuboplasty as a promising therapeutic option in tubal infertility: J Minim Invasive Gynecol, 2011; 18(5); 651-59
16. Norris S, Axelrod C, Sobel M, Chan C, Laparoscopic tuboplasty for mild distal tubal disease: Fertil Steril, 2020; 113(6); 1330-32
17. Sunderam S, Kissin DM, Crawford SB, Assisted reproductive technology surveillance – United States, 2015: MMWR Surveill Summ, 2018; 67(3); 1-28
18. Asplund K, Use of in vitro fertilization-ethical issues: Ups J Med Sci, 2020; 125(2); 192-99
19. Marlow JA, Picus D, Gould J, Outcomes after successful fallopian tube recanalization: A single institution experience: Observational Retrospective study: Clin Imaging, 2021; 76; 70-73
20. Wang JW, Rustia GM, Wood-Molo M, Conception rates after fluoroscopy-guided fallopian tubal cannulation: An alternative to in vitro fertilization for patients with tubal occlusion: Ther Adv Reprod Health, 2020; 8(14); 2633494120954248
21. Al-Omari MH, Obeidat N, Elheis M, Factors affecting pregnancy rate following fallopian tube recanalization in women with proximal fallopian tube obstruction: J Clin Med, 2018; 7(5); 110
22. Thurmond AS, Pregnancies after selective salpingography and tubal recanalization: Radiology, 1994; 190(1); 11-13
23. Pyra K, Szmygin M, Dymara-Konopka W, The pregnancy rate of infertile patients with proximal tubal obstruction 12 months following selective salpingography and tubal catheterization: Eur J Obstet Gynecol Reprod Biol, 2020; 254; 164-69
24. Johnson NP, Review of Lipiodol treatment for infertility – an innovative treatment for endometriosis-related infertility?: Aust NZJ Obstet Gynaecol, 2014; 54(1); 9-12
25. Johnson NP, Farquhar CM, Hadden WE, The FLUSH trial – flushing with Lipiodol for unexplained (and endometriosis-related) subfertility by hysterosalpingography: A randomized trial: Hum Reprod, 2004; 19(9); 2043-51
26. Wang R, Watson A, Johnson N, Tubal flushing for subfertility: Cochrane Database Syst Rev, 2020; 10(10); CD003718
27. Court KA, Dare AJ, Weston-Webb M, Establishment of Lipiodol as a fertility treatment - prospective study of the complete innovative treatment data set: Aust NZJ Obstet Gynaecol, 2014; 54(1); 13-19
28. Dreyer K, van Rijswijk J, Mijatovic V, Oil-based or water-based contrast for hysterosalpingography in infertile women: N Engl J Med, 2017; 376(21); 2043-52
29. Pinto AB, Hovsepian DM, Wattanakumtornkul S, Pilgram TK, Pregnancy outcomes after fallopian tube recanalization: Oil-based versus water-soluble contrast agents: J Vasc Interv Radiol, 2003; 14(1); 69-74
30. Zeng Z, Mo D, Leng Y, New insight of lipiodol flush on pregnancy outcomes in women with recurrent implantation failure undergoing IVF/ICSI: A prospective study based on propensity score matching: Reprod Sci, 2024 [Online ahead of print]
31. Kohi MP, Interventional Radiologist’s approach to fallopian tube recanalization: Tech Vasc Interv Radiol, 2021; 24(1); 100736
32. Phillips J, Cochavi S, Silberzweig JE, Hysterosalpingography with use of mobile C-arm fluoroscopy: Fertil Steril, 2010; 93(6); 2065-68
33. Cobellis L, Argano F, Castaldi MA, Selective salpingography: Preliminary experience of an office operative option for proximal tubal recanalization: Eur J Obstet Gynecol Reprod Biol, 2012; 163(1); 62-66
34. Shen H, Cai M, Chen T, Factors affecting the success of fallopian tube recanalization in treatment of tubal obstructive infertility: J Int Med Res, 2020; 48(12); 300060520979218
In Press
Review article
Characteristics and Associated Risk Factors of Broad Ligament Hernia: A Systematic ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.946710
Clinical Research
Cost-Effective Day Surgery for Arteriovenous Fistula Stenosis: A Viable Model for Hemodialysis PatientsMed Sci Monit In Press; DOI: 10.12659/MSM.946128
Clinical Research
Impact of Periodontal Treatment on Early Rheumatoid Arthritis and the Role of Porphyromonas gingivalis Anti...Med Sci Monit In Press; DOI: 10.12659/MSM.947146
Clinical Research
C-Reactive Protein, Uric Acid, and Coronary Artery Ectasia in Patients with Coronary Artery DiseaseMed Sci Monit In Press; DOI: 10.12659/MSM.947158
Most Viewed Current Articles
17 Jan 2024 : Review article 6,963,884
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 700,363
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 23,797
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 18,566
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912